Spero Therapeutics SPRO Earnings Call Transcripts

NASDAQ SPRO
$1.02 +0.01 (+0.99%)
At close: Nov 11, 2026 · 4:00 PM EST
4 earnings calls on file for Spero Therapeutics, from Q1 2020 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Spero Therapeutics Q2 2026 Earnings Call

Aug 12, 2026 3,376 words · 15 min read
  • Esther RajaveluPresident and Chief Executive Officer
  • Debra ZackChief Medical Officer
  • Shai BiranHead of Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Spero Therapeutics Earnings Call Transcripts

Calls4
LatestAug 12, 2026
SinceQ1 2020

Fiscal 2026

Fiscal 2020

All 4 Spero Therapeutics transcripts Register to get access to Spero Therapeutics’s earnings call transcripts.